Literature DB >> 10884659

Assessment of pulmonary/systemic blood flow ratio after first-stage palliation for hypoplastic left heart syndrome: development of a new index with the use of doppler echocardiography.

J Rychik1, D M Bush, T L Spray, J W Gaynor, G Wernovsky.   

Abstract

OBJECTIVE: Circulatory maldistribution is believed to be a major cause of early death after first-stage palliation for hypoplastic left heart syndrome. Flow reversal in the reconstructed aorta may reflect the pulmonary/systemic blood flow ratio. The purpose of our study was to investigate the utility of arterial PO (2), arterial oxygen saturation, and a newly developed Doppler-derived flow index in predicting the pulmonary/systemic flow ratio after first-stage palliation for hypoplastic left heart syndrome.
METHODS: Twenty-four infants who underwent first-stage palliation for hypoplastic left heart syndrome or a variant were studied. Superior vena cava blood samples were drawn to estimate the mixed venous saturation and permit calculation of the pulmonary/systemic blood flow ratio. Fifty-four samples were evaluated within the first 24 hours after surgery. Simultaneous blood draw and Doppler echocardiography were performed with interrogation in the distal aspect of the arch reconstruction. The ratio of the Doppler velocity-time integral of retrograde flow to the velocity-time integral of forward flow was calculated and compared with the pulmonary/systemic blood flow ratio
RESULTS: The median mixed venous saturation for the 54 samples was low (38.5%; range, 18%-64%). The median calculated pulmonary/systemic blood flow ratio was 1.4:1 (range, 0.3:1 to 4. 2:1). Pulse pressure, mixed venous saturation, and arterial PO (2) were not statistically significant predictors of the measured pulmonary/systemic blood flow ratio. Although both aortic oxygen saturation (R (2) = 0.84, P <.01) and Doppler flow reversal ratio (R (2) = 0.94, P <.001) were significantly associated with the measured pulmonary/systemic blood flow ratio, the model coefficient of determination was greatest for Doppler flow reversal ratio.
CONCLUSION: Measures of arterial oxygen saturation and arterial PO (2) may be misleading in assessing the circulatory status of infants after first-stage palliation for hypoplastic left heart syndrome. Doppler echocardiography, through use of the Doppler flow reversal ratio, provides a more useful measure of pulmonary/systemic blood flow ratio. Low mixed venous saturation after surgery may be due to factors other than pulmonary overcirculation, such as ventricular dysfunction and low cardiac output.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884659     DOI: 10.1067/mtc.2000.106840

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  3 in total

1.  Doppler flow patterns in the right ventricle-to-pulmonary artery shunt and neo-aorta in infants with single right ventricle anomalies: impact on outcome after initial staged palliations.

Authors:  Peter C Frommelt; Eric Gerstenberger; Jeanne Baffa; William L Border; Tim J Bradley; Steven Colan; Jessica Gorentz; Haleh Heydarian; J Blaine John; Wyman W Lai; Jami Levine; Jimmy C Lu; Rachel T McCandless; Stephen Miller; Arni Nutting; Richard G Ohye; Gail D Pearson; Pierre C Wong; Meryl S Cohen
Journal:  J Am Soc Echocardiogr       Date:  2013-03-26       Impact factor: 5.251

2.  Characterization of Post-Operative Hemodynamics Following the Norwood Procedure Using Population Data and Multi-Scale Modeling.

Authors:  Jonathan Primeaux; Arash Salavitabar; Jimmy C Lu; Ronald G Grifka; C Alberto Figueroa
Journal:  Front Physiol       Date:  2021-05-13       Impact factor: 4.566

3.  3D Simulation Analysis of Central Shunt in Patient-Specific Hemodynamics: Effects of Varying Degree of Pulmonary Artery Stenosis and Shunt Diameters.

Authors:  Jiawei Liu; Haiyun Yuan; Neichuan Zhang; Xiangyu Chen; Chengbin Zhou; Meiping Huang; Qifei Jian; Jian Zhuang
Journal:  Comput Math Methods Med       Date:  2020-02-14       Impact factor: 2.238

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.